FIELD: pharmacology.
SUBSTANCE: emulsion contains a base in the form of a perfluoroorganic compound, namely a mixture of oxapperfluoroalkyl bromides of the formula: C2F5O-[CF2CF(CF3)O]n-CF2CF2Br, where n is 1 to 5, the specific gravity is 1.78-1.81 g/cm3, boiling point at atmospheric pressure is not more than 142°C, an emulsifying-stabilizing additive in the form of a block copolymer of ethylene oxide and propylene oxide with a molecular weight of 6000-13000 Da, a nonionic surfactant in the form of fluoroaliphatic ether with a density of 1.1-1.17 g/cm3, a co-emulsifier with stabilizing properties based on phospholipid and physiological solution, with the following ratio of components in the emulsion, vol. %: basis 4.5-45.0; emulsifying-stabilizing additive 0.2-8.0; fluoroaliphatic ether 10-3-10-2; co-emulsifier 0.05-0.50; physiological solution the rest.
EFFECT: technically and environmentally safe manufacturing technology, high stability under different temperature conditions, required dynamic oxygen capacity.
6 cl, 1 tbl, 3 ex
Authors
Dates
2017-09-25—Published
2016-10-11—Filed